Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer-Reference-Cited by-同舟云学术

Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer

Published:2018-09-12 Issue:10 Volume:7 Page:5155-5166
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Yuan Dezheng¹,Chen Hang¹,Wang Shuo²,Liu Furong¹,Cheng Yajie¹,Fang Jin¹^ORCID

Affiliation:

1. Department of Cell Biology; Key Laboratory of Cell Biology; Ministry of Public Health; Key Laboratory of Medical Cell Biology; Ministry of Education; China Medical University; Shenyang China

2. Analytical Instrumentation Center; Shenyang Agricultural University; Shenyang China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1765/fullpdf

Reference60 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Cutsem;Ann Oncol,2014

3. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer;Xu;Asian Pac J Cancer Prev,2013

4. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma;Moriya;Anticancer Res,2013

5. Biomarker studies in early detection and prognosis of breast cancer;Li;Adv Exp Med Biol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of liquid biopsies in gastrointestinal cancer;Clinical Biochemistry;2020-10

2. PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets;BMC Cancer;2020-07-02

Exosomes as Actively Targeted Nanocarriers for Cancer Therapy

;International Journal of Nanomedicine;2020-06

4. NNT‐AS1 enhances bladder cancer cell growth by targeting miR‐1301‐3p/PODXL axis and activating Wnt pathway;Neurourology and Urodynamics;2019-11-29